Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY:DVA)

113.72 -0.69 (-0.61%)
Streaming Delayed Price Updated: 3:27 PM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about DaVita HealthCare Partner

News headline image
Lutheran Home Breaks Ground on State-of-the-Art DaVita Dialysis Den
ARLINGTON HEIGHTS, Ill., Sept. 2, 2025 (SEND2PRESS NEWSWIRE) -- Lutheran Home, part of Lutheran Life Communities, has begun construction on a new state-of-the-art DaVita Dialysis Den on its Arlington... 
Via Send2Press
News headline image
YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities
From YMCA of the USA
Via GlobeNewswire
DaVita Inc. (NYSE: DVA) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
DaVita Inc. (NYSE: DVA) Highlighted for Surprising Price Action
Via Investor Brand Network
DaVita Inc. (NYSE: DVA) Climbs to New 52-Week High
Via Investor Brand Network
DaVita Inc. (NYSE: DVA) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
News headline image
Wall Street Is Cautious on These 2 First Half Winners
There have been many stock winners in 2023 so far, but Wall Street is feeling cautious on these two first half outperformers. 
Via MarketBeat
Topics Economy
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
You may remember learning that mitochondria are the powerhouse of the cells, but do you know the dangers that result if these cell superheroes get sick? 
Via TheNewswire.com
News headline image
Federman & Sherwood Investigates DaVita, Inc. for Data Breach
From Federman & Sherwood
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.